Pharmafile Logo
Pharmafocus logo
Advanced Search

Hansa Medical mourns death of CEO

November 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hansa Medical, pharma

Swedish biopharma firm Hansa Medical broke tragic and unexpected news in November when it announced the death of its CEO …

Appointment
1707_eu-agencies_relocations_website

EMA Headquarters: There’s no place like home

November 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, biotech, brexit, drugs, pharma, pharmaceutical

With the result of the Brexit referendum, the future of the EMA’s London headquarters was cast in doubt. Now, 19 …

Feature
hero-plus

Mylan to withdraw from Tel Aviv Stock Exchange

November 13, 2017
Sales and Marketing Mylan, TASE, pharma

US drug maker Mylan has announced its intention to withdraw from the Tel Aviv Stock Exchange (TASE), ending its involvement …

News
novartis_window

Novartis touts longer-lasting AMD rival to Eylea

November 13, 2017
Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Novartis posted strong results for its wet age-related macular degeneration (AMD) drug, by showing superiority against Eylea in Phase 3 …

News
roche_dark_0

EMA recommends approval of Roche’s Ocrevus in relapsing forms of multiple sclerosis

November 13, 2017
Sales and Marketing MS, Ocrevus, Roche, multiple sclerosis, pharma

Roche has revealed that its humanised monoclonal antibody Ocrevus (ocrelizumab) received a positive recommendation from the Committee for Medical Products …

News
weight-2036971_960_720

UK rates of obesity increased by 92% over two decades

November 13, 2017
Research and Development, Sales and Marketing OECD, biotech, drugs, obesity, pharma, pharmaceutical

A recent report by the OECD shares concerns that the UK’s overall health looks set to face a crisis due …

News
nigeria

Nigerian agency strongly contests that 70% of drugs are fake

November 13, 2017
Manufacturing and Production, Sales and Marketing Nigeria, biotech, drugs, pharma, pharmaceutical, pwC

Nigeria’s drug regulatory body has fiercely countered claims made by Chief Economist of PwC in West Africa, Andrew Nevin, that …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmafile, top ten

Friday again, and we bring you the most read articles on our site this week – one of which was …

News
dynavax

Hep-B vaccine four-year battle for FDA approval is finally won

November 10, 2017
Medical Communications, Sales and Marketing biotech, drugs, dynavax, hepatitis B, pharma, pharmaceutical

Dynavax had said it was the last throw of the dice for its hepatitis B vaccine, Hepislav-B – the data …

News
sanofi_new_paris_hq

Sanofi signs $805 million deal for MS drug

November 10, 2017
Medical Communications, Sales and Marketing Principia Biopharma, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi has decided to build its pipeline in neurological disorders with the agreement to develop Principia Biopharma’s BTK inhibitor candidate …

News
shutterstock_187433765

Breast cancer recurrence can occur up to 20 years after treatment, report shows

November 10, 2017
Medical Communications, Research and Development Cancer, breast cancer, pharma, tamoxifen

New findings from the Early Breast Cancer Trialists’ Collaborative Group have demonstrated that oestrogen receptor-positive (ER-positive) breast cancer is able …

News
child-2916844_960_720

Sage scores good but not great P3 postpartum depression drug results

November 10, 2017
Medical Communications, Research and Development Sage Therapeutics, biotech, drugs, pharma, pharmaceutical

Sage Therapeutics share price soared 50% on the release that its two Phase 3 trials of brexanolone showed statistically significant …

News

Recipharm Interim report January – September 2017

November 9, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Interim report January – September 2017 July – September 2017    

News
Press release

Recipharm to end operations in two facilities in Sweden

November 9, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm today announces that it will initiate a process with the intention of discontinuing manufacturing operations at its facilities in …

News
Press release
nhs_sign

NHS England seals access deals with big pharma for breast cancer and MS

November 9, 2017
Sales and Marketing Cancer, Mavenclad, Merck, NHS, NHS England, NICE, Perjeta, Roche, Simon Stevens, breast cancer, multiple sclerosis

NHS England has entered into a commercial agreement with Merck which aims to provide access to innovative treatments for both …

News
skin-222664_960_720

Gene therapy helps child regrow 80% of skin

November 9, 2017
Medical Communications, Research and Development biotech, drugs, gene therapy, pharma, pharmaceutical, stem cell

A young child has been brought back from the verge of death after an experimental combination of stem cell and …

News
seqirus_08-11-17_full-42_003_web

Seqirus announces £40m UK fill-and-finish flu vaccine facility

November 9, 2017
Manufacturing and Production Liverppol, Novartis, UK, Vaccine, flu, influenza, pharma, seqirus

Seqirus, an influenza vaccine specialist subsidiary of global biotech firm CSL, has announced a £40 million investment into a new …

News
simon-stevens

NHS Chief in high-stakes gambit to boost funding in autumn budget

November 9, 2017
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

It speaks to the desperation of the funding crisis for the NHS that Chief Executive of the NHS, Simon Stevens, …

News
gsk_wall

GSK indicates a return to oncology by appointing Roche veteran

November 9, 2017
Medical Communications GSK, Hal Barron, biotech, drugs, pharma, pharmaceutical

GSK, under its new CEO, has made most of its waves recently not with approvals but with high-profile appointments, and …

News
shutterstock_206748499

17,000 English patients are surviving Stage 4 cancer for two years or more, new data shows

November 8, 2017
Research and Development Cancer, bladder cancer, breast cancer, colon cancer, lung cancer, pharma, prostate cancer

At least 17,000 people in the UK are living with Stage 4 cancer and have survived for two years or …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026